Ernest Mario - Jan 31, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jan 31, 2022
Transactions value $
$20,000
Form type
4
Date filed
2/2/2022, 07:52 PM
Previous filing
Nov 22, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $20K +56.3K +4.09% $0.36 1.43M Jan 31, 2022 Direct F1
holding SLNO Common Stock 311K Jan 31, 2022 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of SLNO common stock. The RSUs are fully vested on January 31, 2022.